Warning: include(/home/radiokgn/public_html/includes/class-admin-list-table.php): failed to open stream: Permission denied in /home/radiokgn/public_html/index.php on line 5

Warning: include(): Failed opening './includes/class-admin-list-table.php' for inclusion (include_path='.:/opt/alt/php54/usr/share/pear:/opt/alt/php54/usr/share/php') in /home/radiokgn/public_html/index.php on line 5

Warning: session_start(): Cannot send session cookie - headers already sent by (output started at /home/radiokgn/public_html/index.php:5) in /home/radiokgn/public_html/libraries/joomla/session/session.php on line 492

Warning: session_start(): Cannot send session cache limiter - headers already sent (output started at /home/radiokgn/public_html/index.php:5) in /home/radiokgn/public_html/libraries/joomla/session/session.php on line 492
'Female Viagra' fails to hit the spot

Warning: Creating default object from empty value in /home/radiokgn/public_html/components/com_k2/models/item.php on line 494

'Female Viagra' fails to hit the spot

Rate this item
(0 votes)

Women taking Addyi, a pill designed to boost their sex drive, get only one additional satisfying sexual experience every second month, according to a Dutch study.

The "female Viagra" has failed to gain a sizable following since it was approved by US regulators in August for premenopausal women. It has side effects including dizziness, sleepiness, nausea and fatigue, the study, published in Jama Internal Medicine, found.

Researchers at Erasmus University Medical Centre, in Rotterdam, analysed the results of eight clinical trials involving 5914 women.

The active constituent, flib-anserin, should not be recommended in treatment guidelines or routinely prescribed until studies prove its benefits in a wider range of women, researchers said.

"The findings suggest the benefits of flibanserin treatment are marginal," they said.

Tage Ramakrishna, chief medical officer at Valeant Pharmaceuticals International, which manufactures Addyi, said that in all three of the drug's pivotal trials there was a significant increase in the number of sexually satisfying experiences women had after taking the drug.

"It is crucial that women suffering from [depressed] sexual desire disorder are able to speak to their physician about the range of options to manage the condition," Ramakrishna said.

 

 

 

 

Source: Bloomberg

Read 469 times
Login to post comments

K2 Tags

Online Radio